We are live on ! Find out more
VTAE

VITAE PHARMACEUTICALS INC COMMON STOCK
VTAE

Delisted

VTAE was delisted on the 24th of October, 2016.

Back to rankings

0 hedge funds and large institutions have $0 invested in VITAE PHARMACEUTICALS INC COMMON STOCK in 2016 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 98 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 98 → 0 (-98)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less capital invested

Capital invested by funds: $504M → $0 (-$504M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 98

Holders
–
Holders Change
-98
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
98
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
AAM
Alpine Associates Management
Florida
-$37.5M
2
Allianz Asset Management
Allianz Asset Management
Germany
-$28.2M
3
TAL
TIG Advisors LLC
New York
-$27.1M
4
WIC
Water Island Capital
New York
-$26.3M
5
MF
Magnetar Financial
Illinois
-$23.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
PWPCM
51
Perella Weinberg Partners Capital Management
New York
– -$1.39M -66,300 Closed
Susquehanna International Group
52
Susquehanna International Group
Pennsylvania
– -$1.31M -62,815 Closed
BCM
53
Bridgeway Capital Management
Texas
– -$1.26M -60,350 Closed
Dimensional Fund Advisors
54
Dimensional Fund Advisors
Texas
– -$1.25M -59,967 Closed
California State Teachers Retirement System (CalSTRS)
55
California State Teachers Retirement System (CalSTRS)
California
– -$1.16M -55,534 Closed
GI
56
GAMCO Investors
Connecticut
– -$1.11M -52,850 Closed
PCM
57
Pentwater Capital Management
Florida
– -$1.05M -50,000 Closed
Marshall Wace
58
Marshall Wace
United Kingdom
– -$1.03M -49,146 Closed
PAM
59
Panagora Asset Management
Massachusetts
– -$1.01M -48,470 Closed
EPM
60
Equitec Proprietary Markets
Illinois
– -$962K -46,000 Closed
Barclays
61
Barclays
United Kingdom
– -$917K -43,855 Closed
TA
62
Teachers Advisors
New York
– -$872K -41,690 Closed
O
63
OppenheimerFunds
New York
– -$770K -36,790 Closed
AA
64
ALPS Advisors
Colorado
– -$769K -36,767 Closed
GC
65
Guggenheim Capital
Illinois
– -$638K -30,529 Closed
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
– -$567K -27,100 Closed
Renaissance Technologies
67
Renaissance Technologies
New York
– -$544K -26,000 Closed
VEA
68
Virtus ETF Advisers
New York
– -$512K -24,463 Closed
RhumbLine Advisers
69
RhumbLine Advisers
Massachusetts
– -$511K -24,424 Closed
WRBC
70
W.R. Berkley Corp
Connecticut
– -$483K -23,071 Closed
ProShare Advisors
71
ProShare Advisors
Maryland
– -$435K -20,788 Closed
Manulife (Manufacturers Life Insurance)
72
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$404K -19,321 Closed
NFA
73
Nationwide Fund Advisors
Ohio
– -$356K -17,030 Closed
AllianceBernstein
74
AllianceBernstein
Tennessee
– -$356K -17,000 Closed
HCMT
75
Highland Capital Management (Texas)
Texas
– -$352K -16,825 Closed
1 2
3
4

VTAE Hedge Fund Activity: Q4 2016 in Review

0 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) for Q4 2016, worth a combined $0 — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 98 funds closed out of VTAE and 0 opened new positions — a net loss of 98 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Alpine Associates Management, exiting entirely with an estimated $37.5M sold.

  • 0 institutional investors held VITAE PHARMACEUTICALS INC COMMON STOCK (VTAE) as of Q4 2016, down from 98 in Q3 2016.
  • Funds reported $0 of VITAE PHARMACEUTICALS INC COMMON STOCK stock for Q4 2016, down 100% quarter-over-quarter.
  • 0 funds opened new VITAE PHARMACEUTICALS INC COMMON STOCK positions in Q4 2016 and 98 closed out, a net change of -98 holders.
  • The largest VITAE PHARMACEUTICALS INC COMMON STOCK seller in Q4 2016 was Alpine Associates Management, an estimated $37.5M sold.

Based on aggregated 13F filings for Q4 2016.